The Beginner’s Guide to Closed-Loop Marketing in Pharma Posted on August 8, 2022February 4, 2025 by Andrii Nikulin Do you remember when sales reps had face-to-face visits and cold phone calls with physicians and other HCPs? In the pharmaceutical industry and healthcare, detailing was a popular tool for demonstrating medical products and services. Nevertheless, it was hardly efficient because it was expensive, looked contradictory, and felt biased. After the healthcare world started shifting to digital, e-detailing as an alternative to traditional detailing diminished the power of sales reps and granted more power to marketers who received access to a multi-channel approach. Since then, pharmaceutical companies could use e-detailing and other medical content across different types of digital communication such as websites, social media, email, and beyond. However, only a few pharma companies could analyze their campaigns and understand their impact on their audiences. All because they began to implement closed-loop marketing (CLM). Let’s find out what CLM stands for in pharma, and how your business can benefit from it. What is Closed-Loop Marketing in Pharma? Closed-loop marketing is an omnichannel model that allows pharma companies to boost conversions and return on investment (ROI) by increasing the number of leads and improving personalized customer experience with real-time feedback and in-depth data analysis. How Does Closed-Loop Marketing Work? If you want your brand to grow and prosper, knowing your lead and treating them as your best friend is the key. Pharmaceutical closed-loop marketing does the job by giving answers to the essential questions: How do leads find a brand, and how do they engage with it for the first time? Why do leads convert into customers, and why aren’t they? What does make new customers trust a brand? The closed-loop marketing process is a cycle that consists of four stages: Launching a marketing campaign. Engaging with customers. Collecting data. Analyzing data. Closing the loop means repeating this cycle over and over. A pharma brand launches a new campaign, collects the relevant data, feels the gaps in its knowledge about the target audience, and starts a new campaign optimized for the needs and preferences of leads. After each cycle, the brand gets more expertise to strengthen the connection with the lead base. How to Get Started with Pharma Closed-Loop Marketing To see the big picture, pharma companies have to build an integrated system based on an accurate marketing strategy and suitable software. Create a Closed-Loop Marketing Pharma Strategy Close-loop marketing allows the marketing and sales teams to join their activities within a healthcare business and get many important insights that will improve the lead generation process in the future. For example, which channels customers prefer for communication and content browsing, what content they value, what’s the best time to engage with them, and tons of other essential data. Here are key components that are necessary for the implementation of a closed-loop strategy in the pharmaceutical industry: Build the key performance indicator (KPI) system. Choose the metrics that will help your business achieve its digital marketing goals with the highest efficiency. Conduct market segmentation. Analyze your top digital marketing channels and segment leads into multiple groups according to their behavior. Plan personalized customer journeys. Tailor individual messages to every group of leads considering their consumer needs and channel preferences and send them at the right time. Take Advantage of Pharma CLM Software When technology prevails, the technical infrastructure that incorporates all the marketing and sales processes together plays a key role. To implement a closed-loop marketing strategy, pharma companies need three primary platforms: Customer relationship management (CRM) platform arranges the gathered data, tracks real-time feedback, and segments leads and customers for marketing campaigns. Marketing automation (MA) platform optimizes the CLM process. Content creation platform develops tailored messages for multiple channels and audiences. The Benefits of Closed-Loop Marketing in Pharma Using up-to-date CLM insights within a single environment powered by next-generation technology is essential for today’s pharma companies and their marketing management. Here are a few significant benefits pharma marketing strategies can have if based on the closing-the-loop approach. Saved Resources Sending accurate information to the right people at the right time reduces the cost-per-lead rate. It lets marketing and sales teams optimize their budgets and spend energy on other activities that make their medical brand much more powerful. Increased Brand Awareness A high level of interaction and communication between the sales and marketing teams grows the level of interaction and communication between the brand and its customer base. In turn, it significantly improves the customer retention rate. Say you have physicians or any other type of HCPs as your target audience. If you perfectly understand them and plan successful customer journeys, they’ll remember you and spread the word about your brand across the healthcare industry lightning-fast. Customer Behavior Prediction When you regularly access relevant CLM data, you have enough information and experience to predict how an HCP can conduct themselves when they receive certain content or visits a particular channel. Not to mention that some of the top companies in the market might already be using artificial intelligence and machine learning to analyze customer behavior patterns. Personalized Content of Higher Quality Content has never been so vital for promoting medical products and services, as well as for increasing sales. High-quality content attracts high-quality leads. And don’t forget that it’s personalized content that’s king. CLM data allows marketers to find out the content preferences of HCPs and create personal content that doesn’t annoy recipients and doesn’t feel like spam. NOTE: A modular content approach can save you up to 60% on personal content creation while improving its quality, management, and distribution across multiple audiences and means of communication. Modular content created on eWizard significantly reduces the medical, legal, and regulatory (MLR) review process. End-to-End CLM Pharma Solution for Your Omnichannel Strategy The better you look after your leads, the more sales and the better ROI your business gets. Omnichannel CLM for pharmaceutical companies is like prophylaxis for patients. High-quality insights perpetually analyzed in a unified marketing system are the best tool for building long-lasting communication with the target audience. Does your brand need assistance with CLM or omnichannel? Viseven can offer you several implementation strategies to enhance the quality of your leads and increase your ROI based on advanced technology and customer experience techniques. Fill out the form below to request a consultation from Viseven’s expert!
Mobile Health Applications for Patient Engagement Posted on July 26, 2022January 31, 2025 by Andrii Nikulin Apart from high-quality care, personalization, and transparency, patients are eager to have more control over their time and day-to-day health activities with easy access to accurate medical information. A healthcare mobile app is a perfect tool to satisfy all these needs. mHealth apps don’t aim to replace doctors and medical devices but to revolutionize the healthcare system by improving healthcare delivery. The revolution in digital health development can potentially exceed customers’ expectations and help attain a higher level of clinical engagement. As wearable technology and mobile devices have already created a new tone of connectivity within the patients-HCPs-pharma triangle, the demand for mobile applications in pharma has become immense. In this article, you’ll find more about mobile health app development, its enormous role in HCP engagement, and the principal outcomes of including mHealth apps in your multichannel or omnichannel marketing strategy. What Is an App in Healthcare? Healthcare apps, or healthcare applications, are software designed to provide users with health-related services, such as online consultations, live chats, appointment scheduling, and more. mHealth apps help professionals deliver more personalized treatment, assist patients worldwide, and collaborate with other experts. Due to the increasing demand and technological advancements, the mHealth market is projected to surpass $269.31 billion by 2032. Healthcare Mobile Apps: A Brief Statistics Overview The number of healthcare apps downloaded worldwide is expected to reach 8.6 billion by 2025. According to Statista, more than 52,000 healthcare and medical apps are available on the Google Play Store worldwide, and over 53,000 mHealth apps are available on the Apple App Store; By 2023, nearly 30% of American adults regularly utilized a health-tracking or management app multiple times daily; The global mHealth app market will reach $68.77 billion in 2024. How mHealth Apps Are Changing Healthcare Hospital in a pocket Patients can take advantage of healthcare services while staying home. With the help of a mobile device, they can get consultations and prescriptions and even send payments. Entire workflow in a mobile device Mobile apps can help healthcare workers remember their daily tasks, browse the documentation, and optimize communication within their teams. Healthcare professionals can conduct quick online checks, access information about their patients within seconds, monitor their health, prescribe medicine, and so on. Mobile platform for pharma Pharma companies can develop a healthcare mobile app where their staff can send propositions, close deals, and do other business activities with partners and clients. Personalized care Users can receive personalized treatment plans, answers to their questions, and medical advice through healthcare apps within a few clicks. This decreases the time needed to contact a doctor and makes healthcare resources more accessible. AI-powered assistance AI-enhanced technology has completely changed the course of the pharmaceutical industry. Apps with AI technology integration offer instant assistance with various patients’ requests, providing them with around-the-clock support. Moreover, AI-driven algorithms can help healthcare organizations analyze patient data, find more effective ways to assist them, and offer better treatment. Benefits of Mobile Apps in Healthcare More powerful brands Revolution in mHealth has stepped ahead. Assistant apps are helping pharma brands boost awareness by approaching the maximum number of smartphone customers. It means pharma brands can quickly improve their marketing campaigns with intuitive navigation to company data such as contacts or other first-hand details, which are always available, accessible, and visible on apps. Improved time management Due to constant direct contact with the audience, applications in healthcare can help physicians save plenty of time and effort. It will streamline HCPs’ workflows, improve productivity, and maintain patient communication agility. Not to mention that people who need medical assistance can schedule or cancel an appointment with a nearby physician using the app. Patient loyalty Mobile medical apps significantly increase transparency with the help of constant remote monitoring, support, and online interactions. It keeps users engaged and involved in each step of their healthcare journey. Data harvesting Mobile health apps can work as a single hub for all medical information — from numerical data to their preferences, emotional reactions, and current behavior patterns. It provides professionals with a complete pack of insights valuable for further care and treatment enhancements. Real-time response Doctors can respond to people who receive medical treatment proactively using mHealth apps while providing effective treatment anytime and anywhere. Patients can request assistance whenever they need it, and an available doctor can consult them immediately. Moreover, mobile app users can avoid going to the doctor over minor problems or questions and just receive all the answers they need right in the app. Main Types of Mobile Healthcare Applications Many types of apps help patients manage and improve their health independently and assist healthcare professionals with multiple tasks. Here are some mobile health applications examples: Patients’ apps Symptom checkers; Reminders and alerts; Applications for remote monitoring; Support for patients with chronic diseases; Health plus applications; Health insurance apps; Mental health apps; Fitness apps; Diet apps. Apps for healthcare professionals Medical calculators; Prescription management; Appointment reminders; Pharma guides and surveys for eLearning. Medical salesforce apps Remote communications; eDetailing scripts and guides; Informational materials. Most In-Demand Patient Engagement Healthcare Apps Medical education Patient engagement healthcare apps support and strengthen learning processes. Instead of wasting time on long-turning educational sessions, these apps give permanent access to up-to-date medical materials, prescription guidelines, diagnostics, and more. Apps for clinical communications Apps of this type simplify interactions between healthcare providers and facilitate quick responses with virtual functionalities, such as voice calling, video conferences, messaging, and beyond. Calculators Such healthcare mobile apps for patients can calculate dosage or offer dosing suggestions based on multiple complex formulas and individual medical parameters. Disease management and diagnostics Various symptom checkers are among the most popular apps used in healthcare. Doctors and other HCPs can stay in touch with their patients to keep track of their drug adherence and lab results, check current health conditions, and coach them in their health journey. For example, doctors use the SkinVision app to identify skin cancer in its early stages. It reveals the diagnosis immediately. Drug reference Such healthcare apps for doctors provide health information about medicine, pharmacology, indications, dosages, interactions, contraindications, costs, and beyond. Patient education and engagement mHealth apps designed specifically for patients can include educational content such as treatment options, health issues, prevention methods, and more. It results in a better experience and a higher satisfaction rate. For example, TalkLife is one of the healthcare apps that help patients talk to people with the same symptoms or illnesses. They can ask for advice or exchange their experiences if they need it. Mobile telemedicine Another great feature in mHealth apps is an implemented video service technology that can provide remote patient monitoring. Doctors and other healthcare professionals can deliver real-time medical assistance to patients through remote video functions. It concerns those who cannot access their healthcare providers directly or get needed care due to remote location or physical disorders. For example, Dr. Now is one of the best healthcare apps for patients to make a video call and reach their physicians anywhere they want. Top Use Cases of Mobile Apps by Viseven Here are some of the best health apps for patients and healthcare professionals Viseven has developed: Dosage calculator for children’s caregivers. The app can calculate dosage and the frequency of pill or suspension administration. All the medical data is based on the criteria of disease as well as on the little patient’s weight; Dosage calculator for parents and HCPs. This app provides instant access to medicine instructions and allows parents or physicians to calculate the accurate dosage; Offline application. This app provides patient care recommendations for specialists in the oncology sphere (adjuvant, neoadjuvant, and surgical therapy); Versatile medical reference app for pharmacists. The app offers diagnostic possibilities and helps users identify a type of pain depending on its location, duration, or intensity. Osteohelp also allows choosing among the best treatment alternatives, investigating its pharmacological properties, route of medical administration, and beyond; Pharmacist’s guide. This app offers a wide range of up-to-date medical education materials for HCPs with various reference videos for clinical procedures; Health app for tracking health. Based on PhoneGap, this hybrid app has a built-in video module and BMI Calculator technology. The mHealth app provides users with the needed medical records regarding their disease, sets up custom pill reminders, and allows them to keep track of their current health situation; Life Plus App. This mHealth app allows program members and pharmacists to share offers with clients. It includes various options such as promotions for top products, redeems and redemptions, and eVouchers. Users receive the latest information continuously and always stay updated. Core Usability Principles for Healthcare Apps The best healthcare apps for patients and HCPs have the following features: Intuitive user experience (UI) and excellent user experience (UX); Simple installation and flawless functioning; Synchronization of data across devices; Safety and security of personal information. Innovations in digital mHealth technologies help augment clinical efficiency, provide accurate diagnoses, and help pharmaceutical brands stand out. mHealth application development includes business analysis, UI/UX design, backend, app development, and quality assurance. As for operating systems, Android and iOS are still at the top. However, Android remains the lead platform for mobile health application development. Need a mHealth app? Viseven is an app healthcare provider that can develop a hybrid, native, or web app for your pharma, healthcare, or life sciences brand, considering your marketing strategy and the needs of your target audience. Download our case study or fill out the form below for more information. We’ll get back to you shortly!
Guide to Strategic HCP Segmentation Posted on July 20, 2022January 31, 2025 by Andrii Nikulin Imagine you wake up an omnichannel marketer and ask: What does omnichannel strategy implementation start with? We bet you’ll say segmentation among the mumbled words. Any decent omnichannel strategy requires proper target audience segmentation; pharmaceutical marketing is no exception. And here’s the thing. Pharmaceutical marketing is a specific area where an omnichannel marketer cannot simply use best practices from other industries and hope they’ll work out. In this article, you’ll discover what’s unique about healthcare professional market segmentation. We’ll stress the main advantages, review the key criteria, and analyze current and future segmentation practices. Before getting started, let’s figure out: What Is HCP in Marketing? HCP’s meaning in pharma has different interpretations. HCPs stand for healthcare professionals, providers, or practitioners. HCPs can be individuals like physicians, dentists, nurses, pharmacists, or institutions like hospitals, clinics, and nursing homes. Healthcare professionals have diverse roles in the industry and engage with patients in various ways. It’s crucial to understand that not all HCPs can be your target audience, however, all HCPs are important when it comes to pharma marketing. What Is HCP Segmentation? (And What Is Not) HCPs segmentation refers to any practice of dividing a target audience into segments according to a set of relevant principles. On an intuitive level, all of us in marketing have that notion: you have a target audience that is a mixed crowd, but you want to be relevant and innovative to as many of them as you can. In other words, instead of offering everyone at a party a glass of wine and a steak, you want to cater to those who won’t go for that first option. In terms of a healthcare professional audience, physicians are different too. No one can reasonably expect that an eDetailing slide or other traditional content focused on patient challenges or costs will compel everyone to consider prescribing. If we take that analogy further, it may seem that the more segments there are, the better. In reality, though, it is not the case. First of all, there is content — if you have too many segments (carefully sliced up by your analysts based on a 12-dimensional matrix), each containing a handful of HCPs, there will be more of these categories than agencies available to craft all that content. Secondly, humans are highly complex. The account you find in one segment today may appear in a different one tomorrow. When done correctly, omnichannel approach is a powerful tool that can furnish monstrous amounts of customer data. Thus, it is crucial to remember what omnichannel audience segmentation is and is not: It is NOT segmenting based on anything you can think of, down to loads of tiny segments just because you can It IS segmenting based on the criteria relevant to your business, brand, and situation Main Benefits of Pharma HCP Segmentation The benefits of well-segmented campaigns are immense. Your tactics are more powerful, and they yield better results. With proper segmentation, you can identify more precise pharma HCP engagement moves. Based on actual needs, these moves are likely to involve HCPs. That impacts conversion even in a non-personal digital promotion channel like online ads. The conversion rate for targeted ads rises from 2.8% to 6.8% — more than twofold. The affinity between brand and customer increases, and it impacts loyalty. Essentially, it’s a principle similar to providing the beyond-the-pill value in pharmaceutical promotion. If life science professional feels there’s so much more to interacting with the brand than just listening to standard central messages, they’re more likely to perceive this value favorably and become loyal brand advocates. Quality leads. One of the best things about doing segmentation right is that once you have identified a segment, the audience within that segment that was under your radar suddenly becomes more accessible. You already have the content and methods to provide them the value they seek. Brand image and perception in the community. Customers form communities, and the power of reviews is enormous. That’s also true of the medical community, with key opinion leaders of different caliber swaying the fates of pharmaceutical products in entire regions. Segmenting your omnichannel campaigns will provide the life sciences professionals with targeted messaging and the reasons they personally need to refer to your brand as a trusted and valued one. Greater content personalization. Segmentation in Pharma allows companies to find the right audience and narrow it down only to those whose needs these businesses can meet. This strategy ensures that every service, piece of content, and even the smallest message or web banner is relatable to the consumers who encounter it. 80% of marketers consider personalization one of the biggest challenges, especially when integrating an omnichannel strategy, which makes segmentation one of the key ways to address this problem. Common Criteria for Pharmaceutical Market Segmentation A segmentation model or pattern is the combination of criteria you choose to segment a life sciences provider target. In some cases, it may be location, specialty, and the number of patients. In other cases, it may be the psychological type (see below), specialty, preferred channel, and beyond. Of course, these examples are too abstract because a more realistic combination is always focused on the brand, campaign, and many other specific factors. Here Are the Elements of Market Segmentation: Demographic data Age and gender Location For B2C: Income Ethnicity Family status For B2B: Industry Company size Position Translating this into the HCP-pharma market, we get: Age and gender Location Family status Specialty Employment at HCO Amount of patients Position in the community Behavioral data Purchasing habits Preferred channel of interaction History of interactions with the brand (frequency, proactivity, and beyond) In healthcare provider segmentation: Prescribing habits (open to innovation/experiment, traditionalist, and beyond) Preferred channel of interaction (rep calls, email, messengers, electronic health record) History of previous interactions (email open-rate, and beyond) Psychological data Personality (introvert/extravert, etc.) Values and priorities Interests For pharma marketing and HCPs, a similar list would apply as well. Geographical data What Is Special About Pharmaceutical Market Segmentation? For the most part, the segmentation components above have been developed in online campaigns, where the marketer is distant from the customer. But the pharma market lives in a different, much more individual reality with CRM and rep calls serving as a good launchpad. Pharmaceutical segmentation makes it possible for companies to find out what they should focus their marketing efforts on. It’s not just about understanding the problem and its solution, but also identifying who might need it and when. HCPs are busy, and usually, you have a window of just a few minutes per day to reach the right audience and make them interested in what you offer. The magic of pharma market segmentation lies in its ability to pinpoint the exact HCPs who would like to hear from you. Say you adopt more channels, each with its own metrics, and then start building a complete picture. How do you combine the two parts in your marketing strategy? It’s where it pays off to look closely at what the industry already has. Problem of Existing HCP Pharmaceutical Practices With the insight-collecting possibilities provided by CRM/CLM and the reps going from doctor to doctor, the market segmentation of the pharmaceutical industry would be more sophisticated for the F2F channel. However, it only seems that. In reality, most companies stick with a simplified segmentation pattern based on their immediate commercial goals. While reps may be instructed (ultimately by the global office) to collect data in the CRM, the actual decision-making for the cycle still often relies on two criteria: Loyalty Prescription potential The problem is that this is brand-centric, not a customer-centric model. Everything revolves around two questions: What can this account contribute to brand promotion, and is it worth it to sway their opinion? Of course, no marketer can escape these two factors, but this only tells how hard to try to engage, not how to engage. In this situation, the representatives possess insights into each healthcare professional, their preferences and psychological traits. However, representatives don’t decide what content to generate, at least directly. And it’s not too helpful with other channels than sales rep calls. By now, a big number of organizations use entire sets of digital channels with email segmentation often existing in a specific universe. Meanwhile, a smarter take on rep-collected metrics involves psychology. Psychographic Market Segmentation Nothing can be more beneficial in crafting high-ROI targeted campaigns than knowledge about the target audience’s psychology. In B2C and FMCG where omnichannel practices first emerged, things are less complicated than in pharma HCP marketing. Regulations don’t overshadow customers’ choices while making prescriptions requires a hefty dose of scientific evidence. However, as noted above, experienced and high-performing reps still use psychology in communications during their calls, if only to establish that famed personal connection with the provider. When you want to expand to multichannel and then omnichannel approach, the last thing you want to lose is that connection. Besides, being aware of what moves this or that segment of physicians to favor the product over others helps create innovative content that performs. That’s why companies are starting to include psychological data into their segmentation models, providing a further dimension. Some CRM systems have fields configured for this data. Currently, not many marketers use them in commercial operations planning, though. The trick here is to define what psychological traits will be helpful outside the CRM and in the global world of omnichannel HCP engagement. That which lies on the surface — introversion/extraversion, Myers-Briggs types, empathy scales — is not very helpful per se. That is until you find combinations that serve to determine common psychological types. For example, you may notice that the more pragmatic, cost-aware physicians are also patient-centric in their values. They’re generally more open to communications with pharmaceuticals regardless of their introversion/extraversion score. Such psychological typing helps develop and generate fragments for rep-triggered email campaigns that reps could combine before sending to HCPs. The same logic can be extended to HCP targeting strategies that include other digital channels. These channels influence healthcare professionals’ choices (and the choice of key messages) and behavior when building omnichannel customer journeys. Emerging Data Layers and Discrepancies As pharmaceuticals are embracing ever more channels, management boards come across targeting principles and models that are traditional to those channels. Take email (mass mailing, not the rep-triggered email). This channel comes with a targeting pattern that includes browser/device use and even habits when the customers open the emails (impacting sending time). The web has targeting practices too involving geolocation and other things tracked with click maps and SEO-related research. Do these models have life in pharmaceuticals? No doubt. Do they have value outside the channels they were developed for? Sometimes. What is the issue to solve? Few people take time to put these multiple models together and filter out what criteria are relevant everywhere, regardless of the channel. Instead of a brand-centric segmentation pattern we covered earlier, multichannel brings about a channel-centric one. This needs to be broken, and this break is part of the transition to the omnichannel experience. Integrating data from different channel-specific platforms is the tech side of the question and is already being implemented at many companies across the market. The next stage is a shift towards a truly customer-centric mindset. New HCP Targeting Practices in Omnichannel Marketing What is the future of HCP targeting and segmentation? What practices are sustainable in an omnichannel model? Various organizations are working on their models, tactics, and methods, but here are some common findings that our expertise at Viseven confirms. Implementation Process Thankfully, there is no need to start from scratch. A good practice is to build upon what your business has aggregated throughout the years: the customer base, CRM data, pharma HCP insights identified by reps, email metrics, and questionnaires. As you add more channels, find out whether the targeting segmentation that seems evident contributes to the overall ROI of the omnichannel campaign, not its channel-bound part. Another essential thing to remember is that segmentation is an ongoing process rather than a once-and-for-all initial step. Omnichannel approach starts with a segmentation process not chronologically but logically. You harvest additional data in the course of an omnichannel campaign. In a recent study, we described a case when the HCPs’ reaction to an automated email resulted in them either moving to the next step, the management changing the key message, or changing the channel to a messenger. It is natural to use the data on a message or channel preferences obtained in this way to segment the audience further along the way, refining the approach. Common Mistake We have briefly alluded to it when talking about the approximation analogy. It’s crucial not to make segmentation a goal in itself — refining here is not about creating an array of categories that multiply to produce a host of additional small segments of a target. It’s the message that matters. One should start thinking about the message (or messages) they want to convey. It’s in connection with the messages you want to get through that you can define what insights are relevant for segmentation solutions. Integrate at Every Step Finally, the most important point is that there should be one governing segmentation pattern above any channel, even above the CRM. That’s what makes the omnichannel approach different from extended multichannel solutions. It’s all about HCPs with their needs and the value your brand brings, not the possibilities of a single channel, however efficient. It requires a common data pool across channels and integration of the corresponding platforms that underlies it. With a robust, integrated omnichannel architecture, you can not only put together the data from CRM, email, web, or social, but make decisions based on the extended picture of customers you have. Currently, only 15% of pharmaceutical companies believe their approach to HCP engagement is omnichannel. This figure is expected to change in the coming years. However, many pharmaceutical organizations continue to grapple with numerous challenges that make their transition to omnichannel marketing impossible, including budget constraints and limited resources. With experience in setting up omnichannel architectures and campaigns based on the customer’s existing infrastructure and behavior, our experts know how to make your current technical and data capacities work to their maximum. Our team will create a new successful omnichannel mindset which you can then extend and scale. If you want to get more practical and actionable information, professional advice, and technical expertise on building a segmentable and segmented omnichannel strategy, contact our experts or fill the form below. We’ll get back to you shortly!
Healthcare Content Marketing Essentials: Channels and Strategies Posted on July 12, 2022February 4, 2025 by Andrii Nikulin Content is king. You’ve probably heard these three words many times. But only a few know that it’s the title of Bill Gates’ essay published on the Microsoft website in 1996. Here’s a little excerpt from it: The Internet also allows information to be distributed worldwide at basically zero marginal cost to the publisher. Opportunities are remarkable, and many companies plan to create content for the Internet. Now, it’s finally true for healthcare and life sciences. In digital marketing, medical content is experiencing groundbreaking changes. Having gotten through the COVID-19 pandemic, we realized the pivotal role of technology in human interaction and business engagement. The Clinician of the Future 2023 report made by Ipsos reflects these significant changes: 73% of respondents see it as favorable for doctors to possess digital expertise, while 71% hold the same view for nurses; 48% consider it desirable for physicians to incorporate AI into clinical decision-making; 55% of clinicians view telehealth as favorable for serving as the primary method for routine checkups in the next 2-3 years, whereas 28% regard it unfavorably. More patients consider themselves customers. More healthcare professionals (HCPs) naturally require the same customer-focused attitude, where face-to-face visits are only the tip of the iceberg. It means that one of the healthcare marketers’ top priorities is to reconsider how they create and provide their medical content. Content management in Pharma has become more than just looking for the target audience and publishing suitable content; it now encompasses a holistic approach that integrates collaboration, data security, compliance, and many other elements. According to the State of Content Marketing 2022 report by Semrush, healthcare content marketing is in the top ten trending searches related to content marketing, with a volume of more than 40,000. If you regularly google the equivalent topics to become a medical content ninja, you’re in the right place. Regardless of your target audience — patients, doctors, pharmacists, or any other group of HCPs — this tutorial will help you: discover the channels that are most necessary in medical content marketing; learn the tips to get started with these channels; grasp the practices to optimize your content strategy in healthcare and make it successful. Prepare a cup of your favorite beverage, and let’s begin! Most Vital Channels for Medical Content Creation A customer-first paradigm has widened the boundaries of medical content, its creation, and its marketing. With that in mind, we highlighted the most vital channels for medical content marketers so far: Medical Websites; Medical Blogs; Landing Pages; mHealth Apps; SMS; Messaging Apps; Social Media; Email; Video. Let’s analyze every channel and see how you can use them within your content strategy. Optimize your medical website content A website is a primary channel for any non-commercial institution or business in healthcare and life sciences. Most of the website traffic comes from search engines. That’s why when you create medical website content, you should optimize it according to the search engine optimization (SEO) practice called on-page SEO or on-site SEO. Also, any specialist who creates medical content for websites should comply with three factors that affect the website quality: User experience (UX) is a set of practices applied to make websites more convenient to visit. In other words, UX is how people feel when engaging with a website and its content. Medical websites with better UX get more conversions; User interface (UI) is the way people interact with a website. The typical UI elements of a medical website are menus, fields, tabs, buttons, and beyond. This specific type of medical website content requires in-depth analysis and research before creating. The level of UX mostly depends on UI; Customer experience (CX) is an overall impression of customers over a business. In other words, CX is how a medical brand engages with its clients. Here’s where website content plays a crucial role, along with customer support. A medical website should have enough content resources to generate traffic and constantly increase it. There are three main types of medical website content resources you can use for that: Webinars. Generate leads by inviting professionals and non-experts to online events to discuss various topics and trends; Events. Tell how your team participates in offline healthcare events such as conferences and presentations; Blog. Post about your business and niche using multiple kinds of healthcare content. Become an authority with an SEO-friendly blog Blogging is the best way to grow a medical website organically. If you regularly fill a medical blog with organic healthcare content, you’ll get the most influential source for increasing your website audience. At a proper pace, website traffic will increase, leading to more readers and conversions. More conversions result in higher profit. Here’s how to produce relevant, captivating, and high-quality healthcare content for this channel: Master SEO techniques. Learn how search engines work to improve the content writing process and boost the positions of your medical content on search engine page results (SERPs). Start with search engine optimization basics such as crawling, indexing, ranking, keyword research, competitor analysis, and link building; Write on multiple topics. Divide your content into a few categories to make it varied and engaging. These categories can include short articles about news and updates in your company (its services and products), research-based long reads, infographics about industry trends, and beyond; Provide unique insights. Publish information that no one posted before to become an industry influencer. Google loves it when content writing on health has real value. It can be case studies about clinical research, articles that contain statistics, interviews with clients (or patients), and beyond; Post regularly. Create content plans and schedule articles every month. The more you post, the more traffic you can generate; Share content via social media and email. That’s how you’ll facilitate the growth of each channel; Be patient. Keep posting no matter what. Blogging brings benefits in the long run. Create landing pages to convert your leads A medical landing page is a single-page website where your leads land after you engage them with your medical content on any other marketing channel. The goal of a medical landing page is to convert a lead into a customer. A medical landing page content depends on its marketing objective. Must-have content elements for a medical landing page: A catchy headline that shows the value; A simple copy that evokes interest; An image that reflects the landing page goal; The lead form for filling the lead’s personal information; A call-to-action button for collecting the lead’s personal information. Develop a mobile app to increase the target audience As of 2024, the global smartphone user base is expected to reach 7.1 billion. In the United States alone, more than 90% of the population owns a smartphone. mHealth apps span various categories among the top five funded digital health sectors in 2023, with consumer demand steadily increasing. The mHealth market size is forecasted to reach $861.40 billion by 2030. Medical content development in mobile apps can increase the target audience of any institution or business that belongs to healthcare: Health apps can be helpful to users who want to improve their health conditions; Healthcare marketing apps can help marketers optimize their daily activities, such as task organization, team communication, customer engagement, results tracking, and beyond; Doctor apps can streamline the medical affairs of healthcare professionals of any kind. In such an app, doctors can store documentation, track patient visits, provide instructions, etc.; Patient apps can assist users in a clinic or hospital with health monitoring, medication reminders, and other features. Note: Viseven can develop a mobile health app of any type according to your requirements and needs. Use SMS as notifications Short Message Service or SMS is a traditional medical content channel used by HCPs to send: Critical information like health alerts or test results; Educational information like diet or pregnancy tips; Reminders about appointments or prescription refills; Feedback collection requests. SMS sending recommendations: Choose the best sending time; Send only the information that has value. Boost customer experience with messaging apps As a decent alternative to SMS, messengers or messaging apps are an effective medical content channel to generate high-quality leads and make customer communication more personal. Here are a few tips to help your company connect with customers in conversation: Develop live chat with a chatbot for your medical website. Boost customer experience and optimize the communication for visitors searching for simple answers for basic information; Enable live chat widgets on your medical website. Allow customers to chat via the platforms they like. For instance, you can add Messenger and WhatsApp chat widgets to your medical website; Test messaging ads. Launch targeted advertising campaigns as an alternative to social media ads. Targeting online ads via messengers can be a profitable opportunity to boost marketing results. For example, Messenger ads can have 61% higher message-per-reach than photo ads on Facebook. When creating content for your messaging ads: Keep a copy short; Use visuals that attract attention. When answering your customers in messaging apps, don’t forget to: Respond quickly to gain their trust; Keep the conversation personal and friendly. Boost social media to build stronger connections Social media is an extraordinary tool that allows medical marketers to re-establish relationships with their audiences using a variety of content formats on multiple platforms. Three factors determine any medical social media strategy: Social media platforms. Before creating medical content for social media, figure out which platforms are the most important for your clients (or patients); Content formats. You’ll need to find the formats to bring more likes and impressions to your accounts. It can be anything from a text publication with a visual to an audio podcast; The type of content. In addition to creating organic posts for free, you can use an advertising platform like Google Ads or Facebook Ads Manager to target different audiences with online ads based on particular advertising objectives. If you want to succeed in creating social media content for healthcare, always listen to the feedback you get in the form of comments and messages, use a positive tone of voice, and be simple and precise. Here are a few important content touchpoints: Inform. Tell the news, schedule events, and do everything for everyone to stay up to date; Educate. Provide professional tips on the topics related to your healthcare niche; Inspire. Share reviews of satisfied clients (or patients), write human behind-the-scenes stories about your business and beyond; Support. Answer people who contact your profiles directly. Have a plan for medical content sent via email Email has always been a tried-and-tested channel in the medical world. However, the laws that worked a few years back have no power anymore. Even die-hard marketing professionals should accept that the email creation process in healthcare has become more consumer-centric. If you’re a rookie in sending such emails, here are a few basic practices to get started: Learn email marketing metrics. They’ll help you measure the success of your email campaigns. The primary metrics are open rate, click rate, bounce rate, conversion rate, spam score, return on investment (ROI), customer lifetime value (CLV), and cost per acquisition (CPA); Choose an email marketing platform. That’s the place where you’ll create and optimize your email campaigns; Segment your audience. It’s the first practice you should exercise once you choose your platform and set your goals. Email segmentation is necessary to send more relevant information and more specific offers; Experiment all the time. This practice is called A/B testing. Test different audiences and content to improve your results. A newsletter is the backbone of the medical content you send via email. Before sending your newsletter, you must have a comprehensive content plan that should conform to three things: Content. Plan the content to send valuable and attractive offers. The main thing here is to learn how to balance information and benefits in your content marketing for healthcare; Time. Choose the best days of the week and time of the day to send your medical content. If you don’t know when to do it, A/B test it; Frequency. Experiment with your emails to know the number of sending days. When creating your medical email, take into account the following: Subject line. Keep it relevant, engaging, straightforward, and short; Preheader. Find the golden middle between its length and the information you need to send; Body text. Pick ready-made email templates from your platform. To get better results, test different templates to find the best option. Shoot videos with best solutions for content (for medical video) Video marketing is one of the most powerful methods to promote healthcare products and services. It’s a perfect alternative to television which has been a traditional patient engagement channel for years. According to HubSpot: 86% of businesses use videos as a marketing tool; 92% of marketers claim videos are an essential part of their strategy. Unless you want to launch advertising campaigns, video is a must-use healthcare marketing practice because it doesn’t require a budget. All you need is a smartphone with a last-generation camera and imagination. It’s okay to focus on several platforms, considering the information above. It depends on your goals, the time you’re ready to spend, and your brand voice. Here’s how content practices on the major platforms differ from each other: YouTube — longer content that reveals the subject with lots of facts and details; Instagram — Stories adorned with text and stickers or tiktokish Reels; TikTok — concise, amusing videos. Here are a few golden rules you need to know before getting started: Viewers got used to watching tons of content every day. Lure their attention within three seconds; Viewers love storytelling. Create stories, not promotions; Test live streaming as an alternative to short and longer videos; Watch the content of your competitors and other creators to get more expertise. Watch a lot. How to Optimize a Medical Content Strategy Medical content can have an immense impact when created and targeted right. But here’s the question. What is medical content writing, designing, and targeting in its essence? It’s a lot of conscious efforts and hard work because marketers must simultaneously engage with multiple channels and hundreds and even thousands of customers. However, two advanced techniques can significantly simplify everything. Build an omnichannel environment Omnichannel marketing is a set of activities that provide customers with a personalized experience by integrating all online and non-digital channels into a single environment. It allows companies to use medical content and fulfill their objectives more effectively thanks to the ability to: Find out what content channels customers use and plan their journey in advance; Segment customers into multiple target groups; Tailor personalized information to customers at the right time and with no spam; Build consistent communication and strong connections with customers Automate omnichannel activities with the help of a single marketing platform. Master modular content creation The modular approach is a marketing practice that streamlines omnichannel pharmaceutical content creation by breaking down content into the tiniest possible semantic pieces called modules. A content creator can reuse, interchange, and customize modules across multiple channels and target audiences, which allows: Reduce content production period; Cut production costs and allocate smaller pharma content marketing budgets; Come up with large-scale personalized segmentation strategies; Accelerate the Medical, Legal, and Regulatory (MLR) review process for pharma content; Dedicate more time to other advertising affairs. Monitor the performance of your content Track how well your medical content performs. How can a marketer always ensure your audience genuinely enjoys your content? First, define the metrics you will track, such as conversions or tracking. Then, choose the tools suitable for the type of content you work with. You can also use various other methods to gather information about the performance of your content, such as polls, surveys, reviews, and more. Keep up with industry trends Every month, at least one trend arrives that everyone will be talking about. So, make the most of current trends to attract more customers and engage with your audience. From personalized medicine to artificial intelligence, a myriad of topics creates tons of discussions all over the internet, and it’s worth adding them to your content marketing ideas for healthcare. Reach out to the community According to The State of Influencer Marketing 2024, 85% of marketers believe that influencer marketing is one of the most effective forms of marketing. Collaborate with experts in the field as much as possible. From writing blog posts in tandem to conducting interviews, collaborating with influencers and experts can significantly boost engagement and enhance your content’s credibility. By partnering with healthcare bloggers and professionals, you can also increase reach thanks to content creators’ large number of followers. End-to-End Pharma Content Management Solution If you want to use omnichannel and modular approaches to accomplish your goals with medical content. In that case, Viseven can develop a custom end-to-end healthcare content management system based on your strategy. Send us an email or a message via a contact form to get a full consultation, and we’ll get back to you shortly. Also, you’re welcome to test eWizard — our content experience platform where you can create modular medical content for multiple channels. Want to learn more about medical content and pharmaceutical content management? Fill out the form below to get a consultation!
7 Ways to Boost Medical Reps Productivity & Maximize Sales Force Effectiveness Posted on June 14, 2022February 4, 2025 by Andrii Nikulin Once there’s an inquiry about improving pharmaceutical sales representatives’ performance, there’s a need to ask a simple question: “What does it mean to be a pharmaceutical representative? What is exactly a pharma rep’s responsibility zone?”. Looking for the answer, you may find that the key role of a pharma representative is to deliver the pharma company’s ideas and messages to the health care reps in a most efficient, understandable, and intelligible way. So, the best way to help pharma reps improve their service is to provide all necessary information, equipment, and opportunities to improve strategies relating to health care professionals. Let’s explore relevant ways to boost pharma sales performance. Who Is a Pharma Representative and How to Become a Pharmaceutical Rep? The pharmaceutical sector stands as one of the most significant assets in many regions worldwide, rendering it among the most promising industries to pursue a career in. And while there are many great opportunities for scientists and doctors, one role truly stands out: a pharmaceutical representative. A pharmaceutical representative, or ‘pharma rep,’ markets pharmaceutical products to healthcare professionals (HCPs) and educates them about new medicines. Typically employed by drug companies and manufacturers, their main goal is to build long-term relationships with HCPs, serving as a key source of information about new medications available in the market. Obtaining a degree related to this job is a crucial initial step toward becoming a professional pharmaceutical representative. The degree can be in any pharmaceutical-related field, such as chemistry or biology. However, earning a degree is just the beginning; there are several additional steps necessary to pursue a career as a pharmaceutical representative: Getting a certification. Many certifications provide learners with the knowledge and skills of a professional pharmaceutical representative, including information about laws, regulations, and standards. Certification is usually not required to get employed, but it will help your resume outshine your competition; Expanding a network. Attending events in the pharmaceutical industry, connecting with experts on social media, and making your account public are good ways to become acquainted with other professionals in the field and discover potential job opportunities; Acquiring the necessary skills. A professional pharmaceutical representative understands how to present to the public and swiftly build relationships effectively. This doesn’t necessarily require being extremely extroverted, but it does entail being adept at engaging with different types of audiences. The role of a pharmaceutical representative is an ideal career path for individuals intrigued by sales and eager to have a job in the pharmaceutical domain. By honing such skills as salesmanship and effective communication and gaining as much field experience as possible, individuals who aspire to excel as pharmaceutical representatives can quickly become the experts in the field. How to Increase Sales in a Pharma Company in 7 Steps? Now, it is time to delve into specific strategies to take Medical Reps’ effectiveness to another level. Start With a Customer-Focused Pharmaceutical Sales Strategy The professional market situation is the driving force behind business as well as industry communication. So, in order to not spend countless hours trying to reach the doctor, pharmaceutical sales rep needs to shift focus toward the consumer model. That said, sales reps utilizing the latest methods of extended interactions between customers in order to see success come their way tend to be on par with their strategy to reach HC providers. One should not underestimate the power of free individualized interaction between pharmaceutical companies, providers and patients. So, there is a need for companies to make structural changes and research new driven approaches to the customers. Integration of technology resources and insights can be of great help in many ways for a sales representative to turn to the patient-oriented system, to reach the target audience at any time, and deliver required information. In addition, it influences the knowledge building process. Not to mention the prolonged, continuing relationships with customers. Equip Pharmaceutical Sales Representatives The level of tech equipment shows the level of preparedness for companies in the industry. When the medical rep is standing at the doctors’ door, ready to knock and start the communication process, they should feel prepared in the way of presenting information and receiving feedback from providers. There’s no need to overload salespeople with tech stuff for every possible moment of life. However, providing a useful CRM solution and presentation platform is an absolute must-have. CRM allows gathering HCP’s data more effectively, whether it is contact information, job description or specific feedback on a product currently on the market. The high-quality CRM solution should be able to provide med reps with a number of relevant communication opportunities, from making calls via VoIP to scheduling emails and messages. All of it makes the communication between med reps and HCPs more effective and efficient at any time and place of choosing. The smart presentation platform is also a necessary part of the communication technology stack for medical sales representatives. The eWizard platform is the best solution that allows both to manage presentations and show them remotely. Prep Pharmaceutical Representatives Your content database contains many different materials for doctors: interactive presentations, learning platforms, web conferences, training, and many more. It works great for HCP involvement and education, so it should also be available for medical pharma reps. You can provide reps with these materials daily as an educational measure to increase their knowledge by making surveys, videos, presentations, and more. As well as the company’s materials education, you should provide them with the latest information about the pharmaceutical industry and sale tactics. It is urgently important for the medical rep who has not more than 3 minutes with the health care provider but must bring some results afterward. The main idea of improving your representative’s involvement level is never to let them say: “let me check this for you. I’ll get back”. Motivate Pharmaceutical Sales Reps Like any other sales representative, medical representativess highly depend on motivation and feedback. A representative’s work consists of many hours spent gathering information and trying to deliver it in the short term to someone who barely wants to listen. A typical sales representative nightmare looks like this: a lot of time and attention spent on something without getting any positive result. Unfortunately, this is not unusual and may lead to employee burnout, which is unacceptable for everyone. Remember that your med reps’ team is a tool for delivering your message to the audience of the pharma industry. You may want to keep this team as healthier as possible: create a motivational ladder, give promotions, share your business plans, and look for a way to inspire every member. An inspired and motivated employee will look for solutions on his own. Raise Awareness Among Pharmaceutical Sales Reps As everyone has access to the internet — and, accordingly, the ability to self-develop — nowadays, HCPs are no exception when it comes to the pharmaceutical industry. Therefore, it’s critically important to gather intelligent data about HCP’s digital activities, responses, and feedback and provide your sales team with it. It works great even for strategic purposes — tracking med reps’ efforts in the chosen region (for example, by geographical criteria) might be made in a few clicks by just opening the correct sales data. Each team, department, and person in the company should clearly understand their responsibilities, tasks, and how they are expected to perform them. Driving more alignment, agility, and productivity into the team conducts ongoing changes and meets the pharma market’s conditions. Let Pharmaceutical Sales Reps Be Brave Another serious motivational factor is the ability to hear ‘no’ and keep going to the next HCP’s door. Accepting failure is extremely important for every medical representative; no matter how experienced they are, they will always have a deal with the client’s denial. Missing a good potential sale leads to frustration which accumulates and, in turn, leads to burnout — this is a traditional way for any pharmaceutical sales rep to quit their job. So, make your team learn from their failures and how to overcome them. The truth is the more you fail and learn from it, the better salesperson you become. Spend time to each your sales representatives to find a lesson in every rejection, so their delivery flow can be flexible and personalized for any difficult circumstances their customers have. Keep in mind that flexibility goes a long way, too many penalties for not making a plan, your employee will mostly think about how not to be fined instead of looking for effectiveness. Keep The Sales Representatives Motivated Great piece of motivation is always inspiring for every person. Try to motivate them in all possible way. There is no better thing, that the belief of team leader in colleagues. A good manager should be able to motivate people to work and be sure of future results. Colleagues are peers and the whole company – a community, a family. Turn everyday work in enjoying process. Indeed, if to inspire employees to see real future goals and results, they will, undoubtedly, work harder, paying attention to every detail. Takeaways As you can see, there are many ways to influence your medical representative’s sales process, make it more profitable and increase pharmaceutical sales force effectiveness. In a nutshell, the best you can do for your team is to try to walk in their shoes and see this sales process from their perspective. This way, you can learn more about what they need, discover more about the inner world of pharmaceutical marketing and get new ideas to increase pharmacy sales. Does it sound good enough to try? Please fill out the form below to contact us and learn about our approaches that will help you be a champion in healthcare engagement and bring your pharma sales force effectiveness to a new orbit.
How to Solve MLR Hurdles with a Modular Approach Posted on May 4, 2022February 4, 2025 by Andrii Nikulin As the unstoppable technological progress flow changes the focus of our daily lives, it also introduces a fresh approach to the field of digital interactions. It becomes quite a challenge for life sciences organizations to keep up with modern marketing trends, especially concerning the highly regulated and compliant pharma and life sciences industries. If you are familiar with anything that is described as MLR review, you probably already know what it means. This acronym represents “medical legal and regulators review” — a process used in which life sciences companies ensure the compliance of their marketing and promotion materials with internal and external regulations and guidelines. Your business can use another name such as MMLR review or MRC review. What is Modular Content? A typical pharmaceutical company spends a massive amount of time and money creating an efficient marketing workflow that needs to go through the medical and legal regulatory review process to get approval later. This approval is the bottleneck moment in the marketing production process. If the medical, legal, and regulatory representative finds the marketing materials accurate, you’re a winner. In any other case, they send your great content back, and you spend more time and money editing the information provided. Essentially, the back and forth complex aspects of this feedback are the worst scenario for marketing content management with strict deadlines and a personal nightmare for content creative teams. This is where the modular content idea comes into play for pharma and life sciences companies and medical legal review MLR for short. The name should speak for itself: basically, a modular content strategy is built around a block of content that describes different data. Although it sounds simple in terms of marketing operations, this solution allows easy access for the medical legal regulatory review. It directly impacts the compliance and review processes. The modular content approach helps management spend less time and effort on content creation, not to mention the savings for the organization. In this article, we will discover what modular content is and how it helps to solve typical MLR hurdles for marketing content management. If you know anything described as an MLR review, you probably already know it. This acronym represents “medical legal regulatory review” — the MLR process in which life sciences companies ensure the compliance of their marketing and promotion materials with internal and external regulations and brand guidelines. MLR reviews are sometimes called MMLR review or MRC review – your business may use either one to describe regulatory compliance. The solution to the MLR review process Content creation takes a lot of time and money, and marketing teams spend a lot of resources trying to find an idea and make it attractive as well as sales-worthy for healthcare providers and the life sciences industry as a whole. When this highly creative and useful content gets cut or even declined by the MLR reviewers, it becomes a major pain for the entire marketing department or even the company. This pain is associated with hindering many processes in the organization, impacting the marketing production process, missing deadlines, work-overs, limiting efficient marketing workflow, and more budget spending. MLR review solutions can be unpredictable, so the modular content was created as a fresh approach to overcome typical MLR process hurdles. This approach makes the life of both MLR review team and content management creative teams – easier. A module is a stand-alone piece of digital content that consists of the main claim and supporting text or media. The easy-to-use blocks separate the content inside the module. These blocks can be predefined and organized according to the main content requirements and used in various forms, from SMM content and emails to interactive presentations like an eDetailer. Among the many advantages of the modules is the possibility of quick MLR reviews approval. Life Sciences Companies’ Problems Solved Time A large amount of original and creative marketing content management takes time to be created and thus approved. It can take up to a few weeks for MLR reviews and its representatives to check the compliance and approve every page or piece of your training materials or guidebooks. Suppose, for some reason, the medical legal and regulatory approvers declined a significant amount of content. In that case, you need to launch the production cycle once again: content needs to be reworked following the medical legal regulatory review solution and applied to the MLR review for approval once again. If everything is fine this time, you get your smooth process ready to go. Otherwise…welcome to yet another round. So, a module is a great solution to eliminate the many complex aspects — it needs to be approved to fit compliance and regulations only once. When it comes to creation, it won’t take time to use prepared assets and templates. Your organization needs to align it with the regulatory policy and send it for review. Once approved, such a module is automatically highlighted for medical legal regulatory compliance representatives, reducing the risk of MLR decline and starting rapid process innovation for life sciences and healthcare professionals. Workload fatigue Workload fatigue is simply a human factor in content management. When you begin to research and write a large amount of information, your eyes may get clouded with words and digits, and anyone in the organization can make an unconscious mistake. This is an unfortunate part of the process for both MLR and content makers: when the marketing team spends weeks creating something useful and original, an exhausted copywriter or designer makes one mistake that entirely spoils and wastes these work hours. Another example: a stressed and overloaded with tons of work regulatory compliance representative declines some presentations because of some small things they found incorrect. Both cases aren’t pretty for management in the face of processes like missing deadlines and budgets. The good thing is that module is built on expertise and templates. Template structure makes it easy to create and edit. Also, it uses only pre-approved information for medical regulators, so there’s no need for additional research or a second check once the module is approved. Such simplicity reduces the possibility of decline because of incorrect information or human error; accordingly, it makes the regulatory compliance i.e., MLR process, faster. Global to local scaling The pharmaceutical business is something that can be scaled up and down. Whether your company works globally or locally, each market has its own medical legal regulatory specifics in different territories. So, every time the management needs to reposition your product in a different country or state, you must change your marketing strategy to follow the local specifics and compliance requirements. It can become a real struggle for the management and content team to re-target the materials for a new market and apply them to MLR review as the content needs to be compliant. Again, the structure of modular content is flexible when it comes to changes. The blocks, templates, and informational fields drive rapid process innovation and can be easily replaced with the required ones while still be in compliance with MLR standards because of the pre-approved and localized content. Different HCP fields It may happen to promote one product in different HCP fields. For example, if you are going to promote the same treatment for different medical fields like endocrinology and gastroenterology, the MLR process will be applied for both directions separately. It requires additional expenses for the management on content creation and doubles the risk of being rejected by MLR in pharma, as each medical field has its requirements. At this point, the module also can be adapted accordingly to the specific case. To avoid many regulatory affairs, you can create a separate module template personalized for different cases and pre-approve it accordingly. Outcome As you can see, the modular content is quite a solid solution to the most common problems related to the MLR review process. The pharmaceutical industry is highly regulated, and thus, the medical legal regulatory process is very demanding for a business presentation, marketing, and promotional materials. Such circumstances make it difficult to develop high-quality content, adapt it to different MLR requirements, and avoid losing time and money. This is where modular content changes the situation. It is flexible, smart, and easy to develop for every case. The simplicity and interchangeability of data inside the module is the core idea that makes modular content a good communication tool that makes the medical legal regulatory review process easy and predictable. Pre-approve content modules for further reuse. Make the MLR approval process predictable — fill out the form below to get personal expertise!
Pharma Content Localization: Best Tactics in 2024 Posted on April 22, 2022February 4, 2025 by Andrii Nikulin Global pharma companies seem to be in a position of advantage when it comes to entering emerging markets (now also dubbed “pharmerging countries”). Why, with bigger R&D possibilities, more advanced digital maturity stages and communication strategies, it seems fulfilling the mission of drug accessibility is as easy as pushing a button at the corporate HQ. At the same time, there are nuances to observe besides translating global content into target language – and at many organizations, the current processes of localizing content simply don’t allow to plug in the additional expertise. This leads to inefficiencies along the way, from internal constraints at local level to inexplicably lower-than-projected ROI. Here, we analyze the benefits of a well-thought content localization strategy – and localization management tools that can help. Global companies, local markets Spending on medicines is growing unequally across the world. According to prognoses, the US share will increase from $485 bln in 2018 to $625 bln by 2023, while the pharmerging countries are expected to spend up to $385 bln, rising from the 2018 baseline of 286 – growing by almost 1/3. Now, these are pre-COVID estimates, but the pandemic has not removed the underlying factors (such as aging populations and consumer awareness) to a considerable extent everywhere. Some more recent research has found the emerging markets will yield CAGR of 10.4% in the half-decade from 2021-26. At the same time, while COVID has not disrupted this growth, it has changed things a lot when it comes to actually penetrating these markets. Traditionally, the use of conventional (but costly) channels of communication like medical reps, has been low in many regions, or field force were insufficiently furnished with visual and other promotional aids. The push toward digital that occurred in Q2-Q3 2020 has given the potential to level the capacities here. Granted, global companies still have the advantage of more mature omnichannel engagement strategies – but simply importing them along with content would be a major mistake. Regional specifics are crucial to make these subtle customer journeys work properly. Meanwhile, the established local markets are growing, too (somewhere in the middle by CAGR), but also much more saturated both with products and communication. Treating these like secondary to global markets by underlocalizing the communications is becoming unacceptable. What is this ‘underlocalizing’, then? Localizing content vs. Localizing strategies While agencies collaborating with pharma have long emphasized that localization does not equal translation, adding the extra parts (like content transcreation, more sophisticated local campaigns) has been reserved to the more conscientious marketers within pharmas themselves. In many cases, operationally, “localization” was a term only applied to content – and content translation, while local affiliates were either copying the global directives, or ignoring the best practices from HQ to go on doing things in the way it had always worked on the spot. Ideally, though, there is a difference between localizing content – and localizing entire strategies. In a particular country, content types and even entire channels preferred may differ from what is expected at HQ, socially acceptable touchpoint frequency may vary from culture to culture, etc. What’s more, even when there is understanding of these two “localizations”, the strategic one invariably influences the content localized. Failing to establish a firm link between them results in squandering opportunities. This is the case of a company localizing wrong content, or a really energetic local manager with a genius strategy being bound to use only partly suitable (but shiny) materials. Establishing this link requires understanding of what content there is already plus the local specifics. In some cases, this leads decision makers to establish local content hubs (or appoint special local liaisons at their Content Factories). Localization besides translation No matter how proficient a translator is, there are things they simply cannot do with words to provide the native look and feel. Someone will have to dive into design and code to fully adapt these. So, what exactly is it that requires content to be transcreated, and not just translated? Visuals. This umbrella term encompasses a lot of factors: what is the visual to text ratio that the customers are comfortable with? What are the preferred data visualization types? For example, while most countries accept the traditional pie charts, graphs, bar charts, etc., the more recent infographic designs are not universally considered aesthetic. Also, do the visuals correspond to the local realities? This has been a pitfall for some AVOD advertisers in Latin America, where 70% users feel underrepresented in the content. Psychology. This includes things like casual attention span (the amount of time a person is willing to dedicate to information before deciding whether to get invested in it). Further down the list are common attention or reaction triggers, as well as perceptions of tone of voice. Some cases are really like an extension of the linguistic T/V phenomenon (like tú vs. Usted in Spanish). This atmosphere of (in)formality exists even beyond words, when HCPs sometimes consider the tone of voice unacceptable or slightly off. Objective regional specifics. Epidemiology of the target condition(s), dominant patient profiles, official guidelines and which are recognized more, affordability, insurance policies – all of these impact the phrasing and choice of key messages. If some material layout proudly presents a box with text saying, “recommended by [association]”, and you have to remove it, what will go there? Coding it all. Supposing you have found the necessary expertise to truly localize the content in all details, who is going to work with all the code? This is the place where the “give-it-to-an-agency-once” model may prove inefficient, because the coders and project managers will perform better when immersed in the context. Additionally, for some content types, it is better to code (and test) with the dominant target platform and device in mind. Making content localization more efficient All of this influences the efficiency of any localization strategy. Needless to say, no matter how developed a strategy can be in the marketer’s mind, the end implementation ultimately can be thwarted by something as simple as ineffective workflows and blown budgets. But how exactly to fix the issue? In practice, whenever Viseven experts are approaching the global content localization solution issue (be it within a Digital Content Factory project or an omnichannel campaign scaled to multiple countries), there are two efficiency factors: internal and external. In the basic ROI equation, you can increase the return by either reducing the initial investment or making sure the net return figure is higher. The “internal” factor is the bottom of the equation, the initial allocation of costs, time, effort (we’re being multidimensional here). You can reduce this by eliminating the “waste” byproducts and processes in something like a Lean approach. This means providing more convenient virtual workplace, establishing better workflows, and so on. On the other hand, the “external” factor in localization efficiency addresses the net return – that is, how much this localized strategy or content yields in the field. To raise this figure, one needs to go beyond localizing content to localizing strategy and tactics (that is why we talked about it earlier), as well as account for local realities. So what would the recommended to-do list look like? Actionable steps Provide convenient UX for translators. Even in cases where localization does equal translating things, there are plenty of nuances that only translators know about. For example, it is often necessary to see where a string of text fits into the visual layout provided by the creative. On the other hand, simply commenting on a PDF file is also inconvenient, especially if the PDF is of a pharmaceutical eDetailing presentation loaded with small print and subscript/superscript figures. When a translator is working, their speed is limited by small distractions like having to format the text or checking the contextual placement. Even when each individual moment of such actions only takes up 2-3 seconds, they add up to much more in the process. This is why we enabled several localization modes in our eWizard content authoring platform to provide a convenient interface. Provide a content authoring platform to implement visual changes. For changes besides translation, the visual design component is important. Even when it’s simply the question of removing a text box or changing the amount of text, such alterations impact the layout. When such changes accumulate (and they do once you want to localize in earnest), giving each and every one of such edits to a developer team as a separate request is no longer feasible. Implementing a low code/no-code content editing platform allows to be flexible on this sort of issues and minimize the investment in paid time and effort. Provide possibility for fast pre-MLR review by local experts (and streamline collaboration between them and project management). There are things that MLR review turns into edits, but which could possibly be nipped in the bud if only someone had a look before submitting the material. Informally, many specialists already do address their colleagues in the know before passing assets to MLR: “hey there, what do you think of it.” This spares time, as the correction loop before MLR is often shorter than after it. Making this practice the norm, and facilitating it with proper tools can help reduce localization time and effort. We even integrated a functionality for pre-MLR review into eWizard platform with interactive preview and commenting mode, notifications, and so on. Provide a platform for content reuse (not to code or recode from scratch) + single standard and access to well-arranged DAM. This is a practice that allows to address both internal and external efficiency factors. Content reuse approaches (from block-based to modular) allow not only to save costs and time on development itself, but also to cover a larger amount of smaller segments with personalized messaging. Instead of a presentation or two plus an email or two, you can enter a local market with a truly personalized campaign (or at least a personalizable one), where you recombine pre-approved modules to deliver messages the way it’s already being envisioned in global offices across companies. Organizationally, to enable this, you need a platform to work with modules, a DAM system that supports them (Veeva Vault PromoMats), integration between the two, and expertise in onboarding the local markets to work in this paradigm. Conclusions At the first glance, ensuring proper localization at all stages may seem a daunting task – but ensuring efficiency with several pinpointed tactics will result in less troubles than continuing to work in the conventional ways. To make this transformation as easy as possible, we at Viseven have supplied the necessary functionalities inside eWizard content authoring platform. This allows us to provide localization services for our customers much more efficiently than before – and also helps many companies to streamline localization themselves. Learn more about how this works and book a free demo, where you can also ask our expert about other available options to facilitate localization. Fill out the form below to request a consultation from Viseven’s expert!
Digital Transformation in Pharma: Barriers and Impact Posted on February 22, 2022February 4, 2025 by Andrii Nikulin Over time, pharma gets under fire due to its excessive talks about ‘digital transformation.’ It needs to be clarified what these words refer to and whether these grandiloquent statements work for actual doctors and patients. How many healthcare professionals and patients have yet to see the impact of digital technologies in the healthcare industry? Has it already improved pharma’s daily operations? Let’s figure out where the pharma sector is on the road to the digital age, how this process is changing how they do business, and how it affects the HCPs and patient engagement. What is Digital Transformation for Pharma companies? “Every digital transformation is going to begin and end with the customer, and I can see that in the minds of every CEO I talk to.” Marc Benioff, Chairman, and Co-CEO, Salesforce. Digital Technology in the pharmaceutical industry pushes us to change, poses challenges we don’t want to take, and makes us move forward. These changes may be dramatic. But when life wants us to grow, it makes us change to remain competitive. The problem is that digital technologies are changing faster than we are, leaving us with no choice but to keep pace. When we speak of digital transformation reshaping, we mean the natural evolution of existing processes with new technologies, introducing patterns and strategies that enhance customer experience, and building a genuine dialogue with the customer. In the pharmaceutical sector, this process was launched three years ago, when the pandemic, without much readiness, forced life sciences to increase their digital innovation culture drastically or, in particular cases, grow it from scratch. Looking back, we may go through all cliches of that period, but the digital shift declared a standard of communication with customers. Digital Transformation Barriers: where are we? Where are we now on the road to digital success? Despite being spurred by the pandemic, the digitalization process runs slowly. In terms of pharma digitalization, there are still many regions on the map where companies’ digital development level is consistently low. This map shows how pharmaceutical companies assess their readiness to become digital organizations. According to this map, the digitalization process among countries remains uneven. This is primarily associated with the poor scalability of implemented solutions among the regions and resilience to changes. Now, 1/3 of pharmaceutical companies believe they need to be better resourced for digital engagement. The other 40% report a need for more talent and the right technology for transformation. It’s important to understand that each industry has its own specifics and digitalization in pharma won’t be as smooth as anywhere else. However, this process highlights the areas where the mindset change should happen and what soft spots digital business processes transformation is designed to cover. How does Digital Transformation reshape the Pharma industry? Digital innovation in the pharma sector can help companies perform better by increasing productivity and reducing costs through collaboration, digital technology centralization to optimize delivery, and empowering a company or department. supply chain A global pharmaceutical company is experimenting with VR in its manufacturing operations. Managers can cut training time in half by creating virtual training programs that render production environments and speed up the path to excellence. streamline processes and marketing efforts Another biopharmaceutical company reduced its marketing spending by 20% by building a global system. The move followed a duplication analysis, in which the company found that up to 60% of localized asset-creation activities were duplicative. The company now has a centralized content center to deliver standardized marketing materials in flexible formats to more than 40 local markets. acquiring talent more efficiently The medical company double-checked the licenses of applicants for a nursing license during the interview. This included visiting the verification website, taking a snapshot of the applicant’s license, and storing the information in the applicant’s file. The HR bot was able to automate 80% of the process. Robotic process automation resulted in a 65% reduction in labor costs and a reduced risk of errors. This freed up the equivalent of one full-time job, allowing employees to focus on more critical activities. Disruptive Technologies and Market Dynamics Digital technologies can help companies deliver a competitive, digitally enabled, engaging, impactful experience to customers, the workforce, and ecosystem external partners. Key disruptive technologies include using digital tools to engage patients and other stakeholders remotely, involving social and other community networks, and personalizing experiences with user data to deliver excellent value. Creating a platform for customer experience.The Patient Service and Care Management Platform delivers consistent patient experiences across all channels and enables treatment adherence and care coordination with an entire network of healthcare providers for each patient. Through connected apps and devices, it supports digital therapy, helps improve patient outcomes, and helps health professionals coordinate patient care management. The platform analyzes internal and external data to gain insight into patient care and interactions and can integrate with the platform to analyze real-world data. Connecting patients, biopharma, caregivers, health care providers, and other stakeholders. The platform helps biopharma companies build partnerships with advocacy groups and providers to enhance patients’ experience with complex, chronic, and terminal diseases. It supports a next-generation digital healthcare network focused on patient support and digital engagement. Patients who consent to share their data receive information and updates from the sponsoring organization (typically biopharma companies and patient advocacy groups) to help navigate their disease. Optimizing the content provided to health care practitioners. A large global biopharmaceutical company has created a self-service portal for more than 30,000 practitioners across Europe to access digital marketing and sales materials in various media. The content shared with each practitioner differs based on previous browsing habits, allowing for custom targeting and enhancing the effectiveness of the marketing approach. Artificial Intelligence in the Pharma Transformation Over the past few years, the use of Artificial Intelligence in the Pharma industry and Life Sciences has become a trending topic. Many pharmaceutical companies are progressively implementing more efficient automated processes that include data-driven decisions and use predictive advanced analytics tools. The next step of this advanced data analytics approach will consist of artificial Intelligence and machine learning. Some of the ways AI is being applied in the pharmaceutical sector today include the following: Manufacturing process improvement Drug development Processing biomedical and clinical data Rare diseases and personalized medicine Identifying clinical trial candidates Predictive forecasting Drug adherence and dosage From early-stage drug discovery to prescribing options, the use of Artificial Intelligence is growing steadily within the pharma industry, with an estimated market volume reaching $10 billions by 2024 (including diagnostics, AI-based medical imaging, personal AI assistants, genomics, and drug discovery). Can we hold the digital transformations back? Remember your life before the pandemic; now, it seems like a dream to you, right? Like no other, these two years greatly impacted our lives, habits, and priorities. In 2019, marketers expected a quick end to the pandemic and a return to routine communication with customers. After three years, again like a dream, the pandemic is slowly receding (at minor restrictions). It begs the question: do we need to digitalize further? And will this process be slowed down now? No. Because the digital shift catalyzed some fundamental changes. Pharma marketing has always been a complicated environment characterized by complex relationships with its target audience. However, the shift towards digital innovation in pharma has exposed many problems that previously needed to be tracked. Searching through the old reports is like getting into a time machine that can take us back to changes that have taken place. The retrospective looks as follows: In 2019, 77% of pharma companies reported issues with content localization/translation. Only 28% could repurpose their content with a little manual effort. Back then, 62% say their organization has yet to make plans for using AI-driven content technologies. The most significant impact of digital technology in the pharmaceutical industry was on HCP engagement. Before COVID-19, 64% of meetings with pharma sales reps were held in person. During the pandemic, this shifted to 65% of meetings being held virtually. The old patters revolve primarily around internal content production issues in the pharmaceutical industry and don’t consider the main factor – HCP’s experiences. Today, searching for personalized experiences for the customer is the cornerstone of all companies that want to withstand competition in the market and have a serious competitive advantage. In the end, we should remember that technology exists to make our life easier. In life sciences, the ultimate goal of Digital Transformation is to introduce new technologies that will allow space and time for more strategic decisions on customers. These technologies should solve the long-standing issues of MLR optimization, content and taxonomy management, and multivendor environment support. Transformation in the Pharmaceutical sector: what it refers to Pharma often speaks clichés, but most critics are associated with a lack of clarification of what it refers to. The pandemic exposed many problems in pharma that, in the new era of communication, cannot remain unresolved. We’ve tried to highlight them all for you to see that Digital Transformation usually touches people, processes, tools, and content, areas where innovations are needed to simplify the internal processes that often hinder the natural evolution of companies toward strategic marketing. Why do we need it? In communicating with our customers, we should remember that the biggest shift occurred in patients’ mindsets. Not speaking their language, we can compare our audience to distant stars we try to reach in the dark. The main driver of prescriptions in the pharma industry is loyalty. The main factor that affects loyalty is the message your brand translates. Feel free to learn about it by checking our pharma digital transformation case study. Companies that help with pharma digital transformation Such professional services companies as Mckinsey, Vaimo, and Viseven are driving Digital Transformation by offering an end-to-end content operating model that is aligned with strategy, and ready for scale and innovation adoption. Viseven combines technology and marketing expertise mastering the entire chain of enablers to deliver a best-in-class digital experience. Contact us to learn more about how we enable digital transformation for pharma businesses of all sizes and maturity levels.
2021 in Pharma: What We Have Learned and Where We Have Won Posted on December 28, 2021November 19, 2024 by Andrii Nikulin Are you still processing 2020? Well, here is the news, 2022 is almost here. And while you are thinking about how it could happen; we can only assume that the last year was so intensive and eventful that no wonder it passed before we knew it. It may seem a bit chaotic at least because it frustrates the hopes of all humanity associated with an early end of the pandemic. But in fairness, we must give the credit to 2021 as the one that brought us one step closer to defeating covid and many other diseases. With ongoing digital transformation and the success of mRNA vaccines, we literally can observe how modern technologies shape the healthcare system of the future. As for pharma marketing, we made a huge step forward to deliver personalized experiences to customers with the widespread of a modular approach and current innovations in omnichannel marketing. Wrapping up this year, let’s look closer at the achievement, hopes, and fears we have for the year we step in and arm ourselves with the most recent data on the hottest topics of 2021: Building a successful communication mix with omnichannel approach The rise of modular content and its role in advanced personalization Balancing of customers’ expectations and data security Collaboration to save the day: Viseven is the part of Veeva’s Digital Factory Accelerator Program (DFAP) The current trends, challenges, and opportunities Searching for a balance between digital and virtual promotion Stepping into 2021, our biggest hope was to draw a line under the period of the coronavirus. The emergency vaccine invention suggested a chance to overcome the pandemic in record time, but the year started with news on new mutated strains. They rained down like a bolt from the blue and now, when the omicron has entered the scene, we realize that the covid period is now an era. What does it mean for pharma? In terms of communication, it prolonged the prevalence of digital communication, making pharma look closer to the mixed communication where face-to-face now is just one channel. New 2021 Veeva Pulse Report demonstrates stability in HCPs’ preferences towards digital with the sixfold growth of virtual meetings. At the same time, it poses the challenge for pharma that now is looking for a balance between offline and digital promotion. Resilience to changes Can we say that pharma’s digital moment has arrived? The digital transformation is on every corner, but the biggest challenge remains the resilience to becoming digital and the unevenness of transformation among regions. This can be explained by the growing complexity of content production and the difficulty of digital tools adoption across regions. Technology is changing and sometimes much faster than we are. Currently 1/3 of pharma believe they are poorly resourced for digital engagement. To win this competition, pharma should ensure that content development process is accelerated to the needed extent. With the introduction of smart content, however, it is easier to keep content creation at scale and navigate the complex digital landscape. The concept assumes content and data to be synchronized and supports supreme enterprise context management (taxonomy, claims, business rules, and tags). It is the whole new approach to content management with more features designed specifically to support rapid content development. Personalization The word of the year in pharma would likely be personalization. Now all the habits that we, as patients and customers, have acquired in 2020 have finally taken root. And pharma is rushing to introduce something extra to the customers as the main ingredient to win this competition. According to Smart Insights, 72% of consumers say they now only interact with marketing messages that are personalized and tailored to their interests. The number of channels has increased giving us additional opportunities to engage customers. However, we must admit that currently we use it blindly, bombarding HCPs with thousands of emails and other messages. To reach customers with the right message, it must be perfectly tailored to their needs. Only then, we can call it personalization. Where pharma won in 2021 Omnichannel to mix it up wisely A digital shift has turned healthcare to reach new heights in omnichannel. After two years, this approach has established its position as a key provider of flexible communication for generation covid who, above all, appreciate empathy, accuracy, and flexibility when it comes to interaction with a healthcare provider. In pharma, omnichannel covered the exposed gaps that were not that obvious before the pandemic. It turned out that besides being one the most expensive channel, according to data on Viseven’s projects, face-to-face visits cannot cover up to 80% of the database. It is especially painful for regions with a stable issue of low audience coverage. Thus, in 2021 pharma chooses to digitize and further actively spends an impressive part of its budget on digital tactics. However, not everything can be achieved by focusing only on digital activities. With HCPs who are still divided into tribes of digital natives and those who prefer in-person communication, face-to-face meetings do not get pale and remain especially important when it comes to product launches. Recovering from a pandemic, it is hard to predict where the channel mix will go further. However, in 2022 only 10% of pharma plan a big increase in budget allocations on-field force activities. And if recently the demand for a mix of virtual and hybrid interaction among HCPs was 85%. Now, this figure has grown to 87%. Top communication channels in 2021 A large number of omnichannel projects we were lucky to have this year allows us to share our internal observations regarding customer preferences and the channel that interest them the most. The email has confirmed its championship with 3x more demand among our pharma customers compared to the previous year. The second most relevant channel was SMS. And especially remarkable this year was for messengers that were in high demand among our customers. At their request, eWizard received a new feature, namely the support of messenger ad content creation for WeChat messenger. For us, these numbers and demands are just a confirmation of the industry’s ambition to move further towards digital and omnichannel excellence. Smart investment into digital The variety of channels, systems, and connections between them captures the imagination at first but later it creates some difficulties as the multiple means of communication make it difficult to track the performance of each activity in the campaign, leaving you in the dark about what you invest in and what you get in the end. Viseven’s experts in omnichannel suggest that pharma can easily drive efficient campaigning with a clear connection of how it influences HCPs’ loyalty and can measure and define the activities that spurge the decision of a particular client. The rise of modular content The widespread modular content has made the trend of personalization sound much louder. Over the years, content production in the pharmaceutical industry was considered a time-consuming process associated with many bottlenecks. The modular approach that was previously practiced exclusively by trailblazers is now entering the pharma mainstream. According to researchers, 54% of pharma use modular content, and a further 40% plan to start. These impressive numbers can be proved by the number of requests Viseven received this year. When we speak of our expertise in modular content, we mean a flexible and reusable digital asset living in the form of modular units that can be father used in various channel-specific templates, channels, and contexts. Modular approach of Viseven eliminates the need for affiliates to create content from scratch, but instead, successfully reuse (localize) global content and reap up to 65% of content development costs. The feature of auto-translation, in its turn, allows to translate only the needed assets that will by further reused. The use of pre-approved content modules can significantly accelerate content production, time to market and ensure rapid MLR approvals. But most importantly, it gives a green light to simplified content production that, in its turn, forces personalization and more creative work with content. Many of our great achievements in 2021 were marked by modular. Auto-tagging has become a feature the year with the ability to synchronize content and data (taxonomy, claims, business rules, and tags) within our Content Experience Platform. eWizard now embodies even more opportunities to sew various experiences together and create a unified, automated, and scalable content development standard for our pharma customers. This can be proved by Viseven’s experience on successful modular implementation in several leading pharmaceutical companies. Follow our updates to be among the first to reveal the details of these success cases. Establishing a secure hierarchy Today balancing between customers’ expectations and data security is the challenge for all who are actively digitizing. Digital technologies empower us to deliver more personalized content, tailored messages and cover the expectations of the target audience. At the same time, unfortunately, it rises data security and access management concerns. These are having a long history in life sciences. The tangled mess of countless laws and regulations don’t make it easier for pharma, posing the great challenge not to lose the customer’s trust, pursuing personalized experiences. 95% of customers say they are more likely to be loyal to a company they trust. Of the greatest features of meta-tags, except making it easier to find the information in the DAM is to provide accesses hierarchy, where each user role includes a certain level of access to certain information. Working with pharmaceutical content implies certain requirements and measures to be followed. The International Standards Organization (ISO) guarantees that the company works according to all required procedures, policies, and guidelines, protects, and has full authority over the Company’s assets. To confirm our determination to protect our customers’ data, Viseven has passed the supervisory audit ISO 27001 and regularly confirms its status and the ability to provide a secure environment for the pharma customers. Partnerships to save the day Partnerships has taken a new sense in pharma over the last year. Collaborative approaches and cross-enterprise collaboration are exactly what helped pharma to pass a rough test it has been put on. If you were reading comics, you know that even the coolest of superheroes cannot cope without trusting a partner on their side. The same goes for our partnership with Veeva aligned with greater achievement catalyzing our powers in aspiration to make healthcare invincible. Digital Factory Accelerator Program (DFAP) is designed and launched by Veeva initiative to provide additional support to narrow circle of Veeva’s customers that are building large-scale Digital Content Factories in place and using Veeva services. We are pleased to announce that Viseven Group is now among the first Veeva’s DFAP Partners. Parting thoughts 2021 was the consolidation of our habits as HCPs and patients and the ways we are consuming services. Agile and flexible communication is what pharma customers are striving for today. The current innovations in omnichannel marketing open up new horizons to meet customers’ needs and offer timely, sequential digital interactions in an appropriate format. The only MUST is the flexible content that will boost a content supply chain and will make it circulate through the omnichannel system. These two absolute prerequisites of today’s HCP engagement can fully be covered, regardless of your current level of digital maturity. Turn to us for assistance and help – Viseven’s mission is to enable digital transformation for businesses of all sizes and digital maturities.
Using omnichannel approach to achieve better HCP engagement: how does it work? Posted on November 22, 2021January 31, 2025 by Andrii Nikulin The pharmaceutical industry has talked about improving communication with HCPs for decades. While even several years ago, “closing the loop” was routinely equaled to traditional rep calls plus maybe a couple of emails, things have changed a lot recently. After the seismic shift of 2020, when the F2F variable temporarily left the equation, one thing became obvious: one-way communication (pharma speaks, HCPs listen) is no longer enough. Where is the guarantee the physicians do hear the message? Where is the value they are expecting? Establishing real, reciprocal HCP engagement is a challenge, yes. However, an increasing number of pharma organizations are using digital and omnichannel approach to resolve it – and successfully so. HCP engagement? Customer experience is the key To understand how to achieve genuine HCP engagement, it is helpful to define what it really is. Nodding at a representative or liking a pharma brand’s social media post – does this count? How far does the interaction really need to go to be considered significant for the overall communication funnel? In reality, it makes sense to define engagement as either a two-way interaction (HCP actively responding to pharma), or any event that can potentially lead to such an interaction (e.g., a physician downloading materials from a portal or subscribing to a service). From the HCP’s viewpoint, all of this happens within a certain “landscape” – their overall experience with the brand. At some point, when this customer experience attains a certain level of value to the HCP, they actively engage to get more. There are two prerequisites: The value already received from the experience (proof that the brand can offer more), e.g., a fruitful conversation with a rep or an interesting webinar The “promised” value – i.e., what the doctor can get if they only click that CTA button or ask the rep/MSL a question, etc. The effects of a well-constructed customer experience are hard to underestimate. In recent research by McKinsey (immunologists, n=600), the doctor’s satisfaction with “prescription journey” (in HCP-to-patient and HCP-to-pharma aspects) had the power to almost double the likelihood of prescribing the product. In other words, the overall experience interacting with the brand (in this case, via the representative) influenced the decision making roughly as much as the convenience factor while leading the patient. Interestingly, this refers to a “rep-only” or “rep-led” scenario. Seeing as how digital resources and channels are gaining more weight and credibility (for example, 46% HCPs reported to trust branded professional web resources in 2019), the power of a coordinated omnichannel experience would be even more impressive. But pharma already has a number of digital channels at disposal. Why is the problem still not obsolete? What could be improved? What areas of improvement are still active? Even though most organizations are, by now, using at least several forms of digital communication (tools, channels), there are factors that undermine the effort when it comes to HCP engagement. Drawing on Viseven’s experience, the most typical ones are as follows: Attempt to “squeeze” as much as possible into a single touchpoint. A tradition from F2F era, when the rep was supposed to deliver a list of obligatory messages within the 2-7 minutes of the call – and an unnecessary constraint in an omnichannel environment. With proper organization, the information to deliver can be split across touchpoints and delivered in the sequence most likely to get the HCP engaged. Lack of personalization. While a “one-size-fits-all” approach to messaging and content may sound temptingly simple, it no longer works well. Other industries, including retail, have raised the bar of expectations for customer experience. Siloed channels. The digital maturity stage immediately preceding omnichannel – “multichannel” really used to presuppose broadcasting the same messages across different channels without actual interconnection or traceability across them. However, this approach severely limits the marketer and only allows to operate in broad, crude segments. Addressing these three areas of improvement at once is the essence of the omnichannel approach as it has emerged lately. Omnichannel in pharma: what is it, actually? Compared to simply having multiple channels, an omnichannel approach presupposes integration and interconnection between these channels. This is the next stage of strategic development, empowered by modern technology to connect the once-separate online and offline platforms into a single, observable and manageable whole. From the HCP’s perspective, this connection between the channels means they are no longer “bombarded” by the same messages in different situations (reps, emails, messengers, web) but rather enjoy a cohesive, meaningful experience with the brand. For the marketer, this approach allows to truly coordinate the channels and touchpoints and arrange the experiences delivered to the HCP. By knowing what the certain physician (individual or group) has been exposed to prior to the next touchpoint, and what the feedback was, the marketer can provide the experience that will engage with more probability. Essentially, the integration of channels and cross-channel campaigning based on data, insights and automation provides the possibility of choice at multiple levels. By having a 360-degree outlook on the target audience, the brand can deliver the right message or information in the right context, and via the right channel at every touchpoint. For example, the understanding of where exactly in the adoption funnel the HCP is right now, the marketer can choose to offer them the information they need at this stage. At the same time, the HCP make choices of their own, based on their interests, needs, and other individual characteristics. These choices contribute to the pool of data that the marketer can then use to provide even better experiences, further reinforcing the connection. Technology and mindset The omnichannel approach is powered by technology, which includes integrated digital tools, Marketing Automation System, and (increasingly) even ML-based tools to account for large amounts of data. At the same time, using omnichannel is also linked to a change in mindset when it comes to operating the entire system. Omnichannel pharma marketing requires the ability to think in terms of customer journeys – and making them automated. Tools help in this process; marketing automation platforms offer journey planners that allow creating of automated flows, where the HCP’s decisions (clicks, reactions, subscribes, etc.) serve as disambiguations in the flow. A certain event (triggered by the HCP) essentially “tells” the algorithm to offer the next touchpoint. Of course, it is best at least at the initial stage of implementation to have a skilled professional arrange the journeys for maximum efficiency. How to increase engagement rate in HCP audience (3 aspects) So how does a pharmaceutical brand use all of this in practice to increase HCP engagement? What to look at? Here is a short checklist. #1 Personalized communication With the advent of digital, the demand for personalized communication has increased. An HCP will not have the time to listen to a rep detailing “obligatory” slides when they are interested in other information they can find online. Is this a problem? Not really, once an omnichannel system is functioning around the brand. Arranging touchpoints across channels, the marketer can ensure that the messages get through, while the HCP retains their right to choose according to their real individual needs. Personalization can be delivered in terms of content, tone of voice, channel mix, and even timing of the touchpoints. #2 Logically crafted Customer Journeys A good customer journey is one that looks good from the HCP’s side, so for building it, the professional has to keep in mind both the campaign goals and the perspective of the customer. For example, a chain of touchpoints that starts as emails, can be programmed to cross over to messengers with the same content if the emails are simply not opened. The same journey can “behave” differently if the HCP opened the email but did not engage with it, switching the tone of voice, supporting material, etc. #3 Using digital to reinforce F2F Digital channels can be used to reinforce the traditional F2F interactions within the same context. For example, a rep call can be followed up by an email or message, further inviting the HCP to engage with content on a portal, website or landing page. Where to start Adopting an omnichannel communication model gives a considerable competitive edge and allows to engage HCPs in meaningful dialogues. Of course, to make it work, an organization will want to account for all the aspects, including technology, mindset, workflows, and even elements of psychology, not to mention the work on data management. As of now, though, this has become easier since pharma does not need to “transplant” best practices from other industries and risk every time. Engaging experts who have overseen omnichannel implementation with industry leaders is the most feasible solution. Viseven Group offers this expertise in all aspects, drawing on dozens of projects for TOP 50 pharmaceutical and Life Sciences enterprises. Learn more about how professional teams can help boost HCP engagement for your brand.